Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  SkyePharma PLC    SKP   GB00B3BFNB64

No quotes available
-- GBp   0.00%
06/10 WINNERS & LOSER : Vectura Shares Rise After Skyepharma Tie Up
06/10 SKYEPHARMA : Cancellation - SKYEPHARMA PLC
06/10 VECTURA : Skyepharma Merger Completed As Scheme Becomes Effective (A..
 SummaryQuotesNewsAnalysisCalendarCompanyFinancials 
Company
SkyePharma Plc engages in the provision of pharmaceutical business.It involves in development and supply of pharmaceutical products.It offers a range of medical solutions such as inhalation products, oral, and others.The company was founded by Ian Roderick Gowrie-Smith on January 8, 1996 and is... 
Sector
Pharmaceuticals
Calendar
03/23Earnings Release
More about the company
Latest news on SKYEPHARMA PLC
06/10 WINNERS & LOSERS SUMMARY : Vectura Shares Rise After Skyepharma Tie Up
06/10 SKYEPHARMA : Cancellation - SKYEPHARMA PLC
06/10 VECTURA : Skyepharma Merger Completed As Scheme Becomes Effective (ALLISS)
06/09 SKYEPHARMA : Court sanction of Scheme of Arrangement
06/08 SKYEPHARMA : Form 8.5 (EPT/RI) - Skyepharma PLC Amendment
06/08 SKYEPHARMA : Form 8.3 - Skyepharma Plc
06/07 SKYEPHARMA : Technology License Agreement
06/07 SKYEPHARMA : To Develop Product For US Opioid Market
06/06 SKYEPHARMA : Form 8.3 -
06/01 SKYEPHARMA : Form 8.3 - Skypepharma PLC
More news
Sector news : Pharmaceuticals - NEC
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/23 Endo International CEO steps down, Campanelli named successor
09/23DJSHIRE : Files 8K - Direct Or Off-Balance Sheet Financial Obligation
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on SKYEPHARMA PLC 
2015End of the technical recovery
More Strategies
Advertisement
Income Statement Evolution
More Financials
Sector and Competitors
1st jan.Capitalization (M$)
SKYEPHARMA PLC0.00%0
JOHNSON & JOHNSON15.66%325 050
ROCHE HOLDING LTD.-11.18%218 395
NOVARTIS AG-8.70%214 744
PFIZER INC.6.13%207 809
MERCK & CO., INC.19.20%174 098
More Results